Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DX-8951f in Hepatocellular Carcinoma
NCT00004108Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 1999
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exatecan in hepatocellular carcinoma (HCC), sponsored by Daiichi Sankyo Co., Ltd.. Started Sep 1999; status: completed.
02
Drugs
exatecan
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00004108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004108.